About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT07494123

Lactase Enzyme Supplementation for Growth and Feeding Tolerance in Preterm Infants

Preterm infants commonly experience feeding intolerance, which can delay advancement of enteral feeding and impair early growth. This randomized double-blind controlled trial evaluated whether lactase...

Lead sponsor: Cairo University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Cairo University

Age

0 - 0 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Preterm infants born before 34 weeks of gestation
•Infants prescribed to start enteral feeding
•Absence of gastrointestinal disorders at enrollment, including necrotizing enterocolitis

Exclusion Criteria

•Congenital heart disease
•Other serious congenital malformations
•Cow's milk protein allergy symptoms such as abdominal distension or increased exhaust
•Diagnosed necrotizing enterocolitis
•Neonatal sepsis
•Legal guardian unwilling to provide informed consent

Related studies

RECRUITINGPhase 1

Safety, PK and PD of FLQ-101 in Premature Neonates

NCT07093255 · Retinopathy of Prematurity (ROP)

Nourishing Tomorrow: Role of Medically Tailored Groceries in Addressing Food Insecurity During Pregnancy

NCT06965530 · Pregnancy Related, Prematurity, and more

Milk for Diabetes Prevention

NCT06513026 · Lactose Intolerance, Lactose Intolerant, and more

Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC).

NCT07192393 · Prematurity; Extreme, Prematurity; Decision Support, and more

An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)

NCT06315556 · Retinopathy of Prematurity, Preterm Infants

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 27, 2026Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment124

Start dateFeb 2022

Last updatedMar 27, 2026

Condition

Prematurity Lactose Intolerance Feeding Intolerance

Locations shown

Cairo University Children's Hospitals

Cairo, Cairo Governorate

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 27, 2026Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions